Medigene's Upcoming Presentations at ASGCT Event in 2024
Medigene's Presence at ASGCT 2024
Medigene AG, a pioneering oncology company, is ready to share groundbreaking advancements at the upcoming American Society of Gene & Cell Therapy (ASGCT). Scheduled for October 16-17, 2024, in a city renowned for its rich history, this event highlights crucial strides in T cell receptor (TCR) therapies. The Company will present a poster showcasing its latest innovations and invite participants to an insightful R&D event.
Company Overview and Focus
Medigene AG, known for its commitment to transforming cancer treatment, focuses on developing TCR-guided therapies that are designed to effectively target and eliminate cancer cells. This mission resonates in their unique End-to-End Platform, which emphasizes the creation of optimal TCRs characterized by sensitivity, specificity, and safety.
Insights into Key Presentations
During ASGCT 2024, Medigene will feature a poster titled "Seamless Integration of a Universal Epitope into Recombinant TCRs for Tagging and Tracking of TCR-T Cells Expressing 3S TCRs." Presented by an esteemed team of researchers, including Dolores Schendel and Kanuj Mishra, this poster will provide valuable insights into the Company's innovative technology, UniTope & TraCR. These advancements are set to refine T cell receptor tagging and monitoring, significantly enhancing immunotherapy efficacy.
Details of the Poster Presentation
The poster presentation is scheduled for October 16, 2024, in Poster Hall 2, Betsy Ross Ballroom, during the designated poster session from 5:30 p.m. to 6:45 p.m. Participants will have the opportunity to interact with researchers and learn more about the applications of these cutting-edge technologies in clinical settings.
Register for the R&D Event
In addition to the poster presentation, Medigene is extending an invitation to its R&D event on October 10, 2024. Slated to commence at 4:30 p.m. CEST, this virtual gathering promises to shed light on the exciting developments in the Company's pipeline, including discussions on TCR-guided therapies like TCR-T, TCR-TCE, and TCR-NK.
Expert Insights and Discussions
This R&D event will feature insights from Dr. David B. Zhen, MD, a Principal Investigator at the Fred Hutchinson Cancer Center and the University of Washington School of Medicine. Dr. Zhen will present an overview of the lead program MDG1015, focusing on its unique treatment strategies for solid tumors that have historically posed significant challenges.
Registration Information
Details for the R&D event registration are as follows:
Date: October 10, 2024
Time: 4:30 p.m. CEST / 10:30 a.m. ET
Location: Virtual
Participants can register for the webcast through Medigene's official platform. An archived version will also be made available on their website post-event for those unable to attend live.
About Medigene AG
As a leader in immuno-oncology, Medigene is steadfast in its commitment to developing therapies that can improve patient outcomes in cancer treatment. Their focus on TCR-based therapies has positioned the Company as a key player in innovative cancer care solutions. Recently, the Company’s lead TCR-T program, MDG1015, gained IND approval and is on track for CTA filing, showcasing the potential to offer significant advancements in treating solid tumors.
Frequently Asked Questions
What is Medigene AG known for?
Medigene AG specializes in developing T cell receptor-guided therapies aimed at eliminating cancer more effectively.
When will Medigene present its poster at ASGCT 2024?
Medigene's poster presentation is set for October 16, 2024, during the ASGCT event.
Who will speak at Medigene's R&D event?
Dr. David B. Zhen, MD, will provide critical insights into Medigene's lead program, MDG1015.
What technologies will Medigene showcase?
Medigene will showcase its UniTope and TraCR technologies, which enhance the precision of T cell receptor identification and monitoring.
How can I register for the R&D event?
You can register for the R&D event through Medigene's website prior to October 10, 2024.
About Investors Hangout
Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/
Disclaimer: The content of this article is solely for general informational purposes only; it does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice; the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. The author's interpretation of publicly available data shapes the opinions presented here; as a result, they should not be taken as advice to purchase, sell, or hold any securities mentioned or any other investments. The author does not guarantee the accuracy, completeness, or timeliness of any material, providing it "as is." Information and market conditions may change; past performance is not indicative of future outcomes. If any of the material offered here is inaccurate, please contact us for corrections.
Related Articles
- Degreed Launches Innovative AI Tools for Workforce Development
- Plug and Play Alberta Welcomes 72 Startups to Fall 2024 Cohort
- Iris Energy's Strategic Moves in Bitcoin Mining and AI Technology
- Adam Jacobs Joins Riemer & Braunstein as New Partner
- Sunnyside's Text Messaging Program Cuts Drinking by 33% in 12 Weeks
- Understanding the Recent Trends Around Rambus and Market Sentiment
- Transformative Dental Solutions: Hybridge Expands into New Region
- Understanding Market Sentiments Around Reliance's Shares
- Understanding Comstock's Recent Market Trends and Sentiment
- Innovative Partnership to Enhance Sports Investment Access
Recent Articles
- Rossby Financial and Seeds Join Forces for Investment Innovation
- Rice University Unveils Bioelectrical Implant for Diabetes Care
- Eliem Therapeutics Rebrands as Climb Bio, Focusing on Immunology
- MIT Federal Credit Union Partners with Upstart for Loans
- Verizon Welcomes Santiago Tenorio as CTO and SVP of Strategy
- InvoiceCloud’s Innovation Shines with Recent Award Wins
- ZenaTech Secures FAA Exemption to Advance Drone Technology
- Nikola Corp Reports Record Truck Sales, Stock Surges Higher
- Vertiv Launches Innovative Lithium Battery Cabinets for HPC
- Verizon Appoints Yago Tenorio as New CTO and Strategy Leader
- Marathon Digital Holdings Reports Strong Bitcoin Production Growth
- Longeveron Inc. Set to Showcase Innovations at ROTH Conference
- Longeveron Inc. to Showcase Innovations at Upcoming Conference
- Empowering Energy Transition: A New Era with CarbonAi and Fiùtur
- GetInsured Partners with BeWell to Transform Health Exchange
- Mullen Automotive's Revenue Surge and Spending Strategy
- DebtBook Introduces Innovative Lease Management Software
- Eli Lilly's $4.5 Billion Medicine Foundry: A Game Changer in Pharma
- Bitwise Asset Management Moves Forward with XRP ETP Filing
- Kigen Introduces Innovative eSIM Solution for IoT Management
- Mario Duarte Takes Charge as Aembit's New CISO
- CoWorx Staffing Services Launches New HR Consulting Solutions
- Revolutionizing Family Healthcare: Sollis Health's New Membership
- RPM International's Resilience: Strong EPS Amid Sales Challenges
- Kashif Syed Joins HDI US as Chief Information Officer
- BillingPlatform Partners With Optimum Media for Enhanced Services
- Gen X Women Need Over $2 Million To Retire Comfortably
- Market Insights: Key Stocks to Watch from CNBC's Final Trades
- TNF Pharmaceuticals Secures Strategic Investment to Propel Growth
- Lando Norris Showcases TUMI's Turin Collection in Style
- Jim Cramer's Insights on Must-Watch Consumer Defensive Stocks
- Enhancing Cybersecurity Skills with Free Courses from Pluralsight
- North Star Capital Fund LLC Sees Impressive Investor Returns
- Thryv Holdings Excels with Strong SaaS Growth Potential
- Xona Accelerates Cybersecurity Investments for Government Growth
- Explore The Frame Astoria: A New Condominium Opportunity
- Innovative Bioelectronic Implant Set to Transform Diabetes Treatment
- A2Z Cust2Mate Solutions Unveils Innovative Share Offering
- Empowering Churches: The State of the Church Initiative
- Benchmark Upholds Buy Rating for J.B. Hunt Amid Challenges
- EMCORE Receives Buy Upgrade Amidst Acquisition Proposals
- Republic Services Unveils Circularity Index for Sustainable Business Practices
- First Solar Anticipates Growth from New Import Tariffs
- Graeter's Ice Cream Unveils Exciting Holiday Flavors and More
- 5E Advanced Materials Welcomes Mark Zamek as VP for Products
- GetInsured Partners with BeWell to Transform Health Coverage
- Truist Boosts Price Target for Willis Towers Watson Amid Changes
- Espolòn Tequila Celebrates Día de los Muertos with Flor de Oro
- Mizuho's Optimistic Outlook for CVS Health's Future Prospects
- BMO Affirms Positive Outlook for Capstone Copper Shares